C12N 9/14
Hydrolases
Official title: Hydrolases (3)
C12N9/14 (Hydrolases) appears on 21,423 US grants and 31,293 published applications in this corpus.
Search patents in C12N- Granted patents
- 21,423
- Published applications
- 31,293
- Assignees
- 7,648
- Inventors
- 50,000
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 38 | 0 |
| 1977 | 45 | 0 |
| 1978 | 56 | 0 |
| 1979 | 24 | 0 |
| 1980 | 30 | 0 |
| 1981 | 44 | 0 |
| 1982 | 48 | 0 |
| 1983 | 41 | 0 |
| 1984 | 60 | 0 |
| 1985 | 53 | 0 |
| 1986 | 52 | 0 |
| 1987 | 75 | 0 |
| 1988 | 88 | 0 |
| 1989 | 86 | 0 |
| 1990 | 130 | 0 |
| 1991 | 148 | 0 |
| 1992 | 175 | 0 |
| 1993 | 224 | 0 |
| 1994 | 238 | 0 |
| 1995 | 234 | 0 |
| 1996 | 274 | 0 |
| 1997 | 387 | 0 |
| 1998 | 631 | 0 |
| 1999 | 630 | 0 |
| 2000 | 531 | 0 |
| 2001 | 619 | 84 |
| 2002 | 574 | 809 |
| 2003 | 507 | 1224 |
| 2004 | 392 | 882 |
| 2005 | 339 | 775 |
| 2006 | 493 | 704 |
| 2007 | 448 | 576 |
| 2008 | 390 | 597 |
| 2009 | 327 | 820 |
| 2010 | 473 | 805 |
| 2011 | 503 | 841 |
| 2012 | 519 | 884 |
| 2013 | 547 | 905 |
| 2014 | 657 | 1042 |
| 2015 | 630 | 1084 |
| 2016 | 691 | 1199 |
| 2017 | 705 | 1210 |
| 2018 | 752 | 1340 |
| 2019 | 867 | 1671 |
| 2020 | 980 | 1751 |
| 2021 | 985 | 1875 |
| 2022 | 1006 | 1933 |
| 2023 | 895 | 2066 |
| 2024 | 978 | 2384 |
| 2025 | 1055 | 2165 |
| 2026 | 749 | 1667 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Protease composition6 Oct 2026US 12,751,997 B2Anatara Lifesciences Limited
- Disruption of CD28-sialoside ligand complexes to enhance T cell activation6 Oct 2026US 12,752,014 B2The Scripps Research Institute
- Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene6 Oct 2026US 12,752,019 B2Precision BioSciences, Inc.
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Enzymatic modification of galactolipids in food8 Oct 2026US 2026/0305624 A1International N&H Denmark Aps
- Combination of nonmaltogenic exoamylase and glucoamylase for improving bread resilience and reducing amount of added sugars8 Oct 2026US 2026/0305625 A1International N&H Denmark Aps
- Method for producing plant-based cheese8 Oct 2026US 2026/0305639 A1Amano Enzyme Inc.
- Method for producing soybean composition having improved flavor8 Oct 2026US 2026/0305651 A1Godo Shusei Co., Ltd.
Most cited
By later US patents
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- CRISPR-Cas systems and methods for altering expression of gene products1,186US 8,697,359 B1Massachusetts Institute of Technology · 2014
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998